L56.0

Clinical Causes: Use of certain medications known to increase skin sensitivity to sunlight, such as some antibiotics (e.g., tetracyclines), non-steroidal anti-inflammatory drugs (NSAIDs), diuretics, and certain antidepressants. Exposure to UV radiation from sunlight or artificial sources like tanning beds during medication therapy. Application of topical medications that contain photosensitizing agents, leading to localized skin reactions upon UV exposure. Ingestion of herbal supplements or natural products that have photosensitizing properties, especially when combined with UV exposure.

Key Symptoms: Rapid onset of redness, erythema, and swelling of the skin after UV exposure. Burning sensation or pain in affected areas. Development of blistering or peeling skin, resembling severe sunburns. Itching and increased skin sensitivity in exposed regions. In some cases, swelling and systemic symptoms like fever or malaise may occur if the reaction is severe.

Diagnosis Path: Diagnosis primarily involves a detailed medical history review, focusing on recent medication use and exposure to sunlight or other UV sources. A physical examination assesses the extent and characteristics of the skin reaction. In some cases, healthcare providers may perform photopatch testing to confirm sensitivity to specific drugs. No specific laboratory tests are typically required, but tests to rule out other skin conditions may be performed as necessary.

Treatment Protocols: Discontinuing or avoiding the suspected medication under medical supervision. Protecting affected skin areas from further UV exposure by wearing protective clothing and using broad-spectrum sunscreens. Using soothing topical agents such as corticosteroid creams or antihistamines to reduce inflammation and discomfort. Applying cool compresses to alleviate burning sensations. In severe cases, systemic medications like oral corticosteroids may be prescribed to manage inflammation. Educating patients about the importance of sun avoidance and protective measures during and after treatment. Monitoring for any signs of secondary skin infections or complications.